The University of Chicago Header Logo

Connection

Stephen Kent to Humans

Back to Details
This is a "connection" page, showing publications Stephen Kent has written about Humans.
Stephen Kent
Connection Strength
1.120
Humans
  1. Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines. JCI Insight. 2025 Jan 09; 10(4).
    View in: PubMed
    Score: 0.029
  2. Patient-Specific Nanoparticle Targeting in Human Leukemia Blood. ACS Nano. 2024 10 22; 18(42):29021-29035.
    View in: PubMed
    Score: 0.029
  3. Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 2024 10 01; 18(39):27077-27089.
    View in: PubMed
    Score: 0.029
  4. Fc-mediated functions and the treatment of severe respiratory viral infections with passive immunotherapy - a balancing act. Front Immunol. 2023; 14:1307398.
    View in: PubMed
    Score: 0.027
  5. Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines. Nat Rev Immunol. 2023 03; 23(3):135-136.
    View in: PubMed
    Score: 0.026
  6. Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. ACS Nano. 2022 08 23; 16(8):11769-11780.
    View in: PubMed
    Score: 0.024
  7. Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence. Immunol Cell Biol. 2022 01; 100(1):49-60.
    View in: PubMed
    Score: 0.023
  8. Vaccination after prior COVID-19 infection: Implications for dose sparing and booster shots. EBioMedicine. 2021 Oct; 72:103586.
    View in: PubMed
    Score: 0.023
  9. Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure. EBioMedicine. 2021 Aug; 70:103518.
    View in: PubMed
    Score: 0.023
  10. Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity. Adv Healthc Mater. 2021 05; 10(10):e2002142.
    View in: PubMed
    Score: 0.022
  11. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood. ACS Nano. 2020 11 24; 14(11):15723-15737.
    View in: PubMed
    Score: 0.022
  12. Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults. Vaccine. 2020 02 28; 38(10):2368-2377.
    View in: PubMed
    Score: 0.021
  13. The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens. Immunol Cell Biol. 2020 04; 98(4):253-263.
    View in: PubMed
    Score: 0.021
  14. Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies. Adv Healthc Mater. 2019 05; 8(9):e1801607.
    View in: PubMed
    Score: 0.019
  15. Racemic & quasi-racemic protein crystallography enabled by chemical protein synthesis. Curr Opin Chem Biol. 2018 10; 46:1-9.
    View in: PubMed
    Score: 0.018
  16. HIV Reactivation after Partial Protection by Neutralizing Antibodies. Trends Immunol. 2018 05; 39(5):359-366.
    View in: PubMed
    Score: 0.018
  17. Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults. J Infect Dis. 2017 12 27; 217(1):12-23.
    View in: PubMed
    Score: 0.018
  18. Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults. Vaccine. 2017 11 07; 35(47):6451-6458.
    View in: PubMed
    Score: 0.018
  19. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Sci Transl Med. 2017 Aug 09; 9(402).
    View in: PubMed
    Score: 0.017
  20. Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption. J Virol. 2017 08 01; 91(15).
    View in: PubMed
    Score: 0.017
  21. Dimeric Fc? Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fc? Receptor Antibodies Induced by the RV144 Vaccine Trial. J Immunol. 2017 07 15; 199(2):816-826.
    View in: PubMed
    Score: 0.017
  22. Thiol-Reactive Star Polymers Display Enhanced Association with Distinct Human Blood Components. ACS Appl Mater Interfaces. 2017 Apr 12; 9(14):12182-12194.
    View in: PubMed
    Score: 0.017
  23. Antibody-dependent cellular cytotoxicity and influenza virus. Curr Opin Virol. 2017 02; 22:89-96.
    View in: PubMed
    Score: 0.017
  24. NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity. AIDS Res Hum Retroviruses. 2016 Oct/Nov; 32(10-11):1089-1096.
    View in: PubMed
    Score: 0.016
  25. Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine. J Virol. 2016 06 15; 90(12):5724-5734.
    View in: PubMed
    Score: 0.016
  26. Influenza-Specific Antibody-Dependent Phagocytosis. PLoS One. 2016; 11(4):e0154461.
    View in: PubMed
    Score: 0.016
  27. What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins. EBioMedicine. 2016 Jun; 8:277-290.
    View in: PubMed
    Score: 0.016
  28. Efficient Total Chemical Synthesis of (13) C=(18) O Isotopomers of Human Insulin for Isotope-Edited FTIR. Chembiochem. 2016 Mar 02; 17(5):415-20.
    View in: PubMed
    Score: 0.016
  29. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells. J Virol. 2016 02 15; 90(4):2021-30.
    View in: PubMed
    Score: 0.016
  30. The critical role of peptide chemistry in the life sciences. J Pept Sci. 2015 Mar; 21(3):136-8.
    View in: PubMed
    Score: 0.015
  31. Simian immunodeficiency virus infection and immune responses in the pig-tailed macaque testis. J Leukoc Biol. 2015 Mar; 97(3):599-609.
    View in: PubMed
    Score: 0.015
  32. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015 Feb; 93(2):177-88.
    View in: PubMed
    Score: 0.014
  33. Editorial overview: synthetic biomolecules. Curr Opin Chem Biol. 2014 Oct; 22:viii-xi.
    View in: PubMed
    Score: 0.014
  34. Bringing the science of proteins into the realm of organic chemistry: total chemical synthesis of SEP (synthetic erythropoiesis protein). Angew Chem Int Ed Engl. 2013 Nov 11; 52(46):11988-96.
    View in: PubMed
    Score: 0.013
  35. Native chemical ligation at Asx-Cys, Glx-Cys: chemical synthesis and high-resolution X-ray structure of ShK toxin by racemic protein crystallography. J Am Chem Soc. 2013 Aug 14; 135(32):11911-9.
    View in: PubMed
    Score: 0.013
  36. Racemic protein crystallography. Annu Rev Biophys. 2012; 41:41-61.
    View in: PubMed
    Score: 0.012
  37. Convergent chemical synthesis of [lysine(24,38,83)] human erythropoietin. Angew Chem Int Ed Engl. 2012 Jan 23; 51(4):993-9.
    View in: PubMed
    Score: 0.012
  38. Design and folding of [GluA4(ObetaThrB30)]insulin ("ester insulin"): a minimal proinsulin surrogate that can be chemically converted into human insulin. Angew Chem Int Ed Engl. 2010 Jul 26; 49(32):5489-93.
    View in: PubMed
    Score: 0.011
  39. Total chemical synthesis of proteins. Chem Soc Rev. 2009 Feb; 38(2):338-51.
    View in: PubMed
    Score: 0.009
  40. Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial. J Infect Dis. 2025 Dec 20; 232(6):1319-1329.
    View in: PubMed
    Score: 0.008
  41. HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes. Proc Natl Acad Sci U S A. 2025 Sep 09; 122(36):e2503145122.
    View in: PubMed
    Score: 0.008
  42. Genetic markers of enhanced functional antibody responses to COVID-19 vaccination. Vaccine. 2025 Aug 13; 61:127379.
    View in: PubMed
    Score: 0.008
  43. Deconvoluting TCR-dependent and -independent activation is vital for reliable Ag-specific CD4+ T cell characterization by AIM assay. Sci Adv. 2025 Apr 25; 11(17):eadv3491.
    View in: PubMed
    Score: 0.007
  44. Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles. Vaccine. 2025 02 06; 46:126668.
    View in: PubMed
    Score: 0.007
  45. Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. PLoS Pathog. 2024 Dec; 20(12):e1012739.
    View in: PubMed
    Score: 0.007
  46. SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years. Proc Natl Acad Sci U S A. 2024 Sep 24; 121(39):e2411428121.
    View in: PubMed
    Score: 0.007
  47. Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm. 2024 Nov 15; 665:124695.
    View in: PubMed
    Score: 0.007
  48. Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin. Nat Microbiol. 2024 Aug; 9(8):2073-2083.
    View in: PubMed
    Score: 0.007
  49. Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster. EBioMedicine. 2023 Dec; 98:104878.
    View in: PubMed
    Score: 0.007
  50. Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19. Immunol Cell Biol. 2023 Nov-Dec; 101(10):964-974.
    View in: PubMed
    Score: 0.007
  51. Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza. JCI Insight. 2023 07 24; 8(14).
    View in: PubMed
    Score: 0.007
  52. Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities. Nat Immunol. 2023 06; 24(6):966-978.
    View in: PubMed
    Score: 0.007
  53. Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine. EBioMedicine. 2023 Jun; 92:104574.
    View in: PubMed
    Score: 0.006
  54. Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and ?d T cell perturbations. JCI Insight. 2023 04 10; 8(7).
    View in: PubMed
    Score: 0.006
  55. Robust SARS-CoV-2 T cell responses with common TCRaß motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells. Cell Rep Med. 2023 04 18; 4(4):101017.
    View in: PubMed
    Score: 0.006
  56. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses. Immunity. 2023 04 11; 56(4):879-892.e4.
    View in: PubMed
    Score: 0.006
  57. Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses. Adv Healthc Mater. 2023 07; 12(17):e2202595.
    View in: PubMed
    Score: 0.006
  58. Circulating effector ?d T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals. Immunol Cell Biol. 2023 04; 101(4):321-332.
    View in: PubMed
    Score: 0.006
  59. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques. PLoS Pathog. 2022 10; 18(10):e1010891.
    View in: PubMed
    Score: 0.006
  60. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Front Immunol. 2022; 13:889372.
    View in: PubMed
    Score: 0.006
  61. SARS-CoV-2-specific T cell memory with common TCRaß motifs is established in unvaccinated children who seroconvert after infection. Immunity. 2022 07 12; 55(7):1299-1315.e4.
    View in: PubMed
    Score: 0.006
  62. A Quantitative Approach to Unravel the Role of Host Genetics in IgG-Fc?R Complex Formation After Vaccination. Front Immunol. 2022; 13:820148.
    View in: PubMed
    Score: 0.006
  63. Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles. Sci Immunol. 2022 01 28; 7(67):eabf5314.
    View in: PubMed
    Score: 0.006
  64. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2. EBioMedicine. 2021 Dec; 74:103729.
    View in: PubMed
    Score: 0.006
  65. Influenza lineage extinction during the COVID-19 pandemic? Nat Rev Microbiol. 2021 12; 19(12):741-742.
    View in: PubMed
    Score: 0.006
  66. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021 Dec; 74:103699.
    View in: PubMed
    Score: 0.006
  67. Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians. Proc Natl Acad Sci U S A. 2021 10 12; 118(41).
    View in: PubMed
    Score: 0.006
  68. Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain. Cell Rep. 2021 10 12; 37(2):109822.
    View in: PubMed
    Score: 0.006
  69. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021 08 23; 6(16).
    View in: PubMed
    Score: 0.006
  70. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein. J Biol Chem. 2021 09; 297(3):101065.
    View in: PubMed
    Score: 0.006
  71. Quantitatively Tracking Bio-Nano Interactions of Metal-Phenolic Nanocapsules by Mass Cytometry. ACS Appl Mater Interfaces. 2021 Aug 04; 13(30):35494-35505.
    View in: PubMed
    Score: 0.006
  72. SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph. Immunol Cell Biol. 2021 10; 99(9):990-1000.
    View in: PubMed
    Score: 0.006
  73. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021 09 01; 131:16-40.
    View in: PubMed
    Score: 0.006
  74. Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
    View in: PubMed
    Score: 0.006
  75. Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients. Nat Commun. 2021 05 11; 12(1):2691.
    View in: PubMed
    Score: 0.006
  76. Interactions of core cross-linked poly(2-oxazoline) and poly(2-oxazine) micelles with immune cells in human blood. Biomaterials. 2021 07; 274:120843.
    View in: PubMed
    Score: 0.006
  77. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 05 11; 54(5):1066-1082.e5.
    View in: PubMed
    Score: 0.006
  78. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
    View in: PubMed
    Score: 0.006
  79. A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth. ACS Chem Biol. 2021 03 19; 16(3):548-556.
    View in: PubMed
    Score: 0.006
  80. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
    View in: PubMed
    Score: 0.006
  81. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol. 2020 12; 20(12):727-738.
    View in: PubMed
    Score: 0.005
  82. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24384-24391.
    View in: PubMed
    Score: 0.005
  83. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020 10; 5(10):1185-1191.
    View in: PubMed
    Score: 0.005
  84. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434.
    View in: PubMed
    Score: 0.005
  85. Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network. Small. 2020 08; 16(33):e2002861.
    View in: PubMed
    Score: 0.005
  86. High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vd2+ T Cell Subset with a MAIT Cell-like Transcriptional Profile. Cell Rep. 2020 06 16; 31(11):107773.
    View in: PubMed
    Score: 0.005
  87. Butyrophilin 2A1 is essential for phosphoantigen reactivity by ?d T cells. Science. 2020 02 07; 367(6478).
    View in: PubMed
    Score: 0.005
  88. Impact of HIV-1 viremia or sexually transmitted infection on semen-derived anti-HIV-1 antibodies and the immunosuppressive capacity of seminal plasma. Eur J Immunol. 2019 12; 49(12):2255-2258.
    View in: PubMed
    Score: 0.005
  89. Differential Roles of Plasma Protein Corona on Immune Cell Association and Cytokine Secretion of Oligomeric and Fibrillar Beta-Amyloid. Biomacromolecules. 2019 11 11; 20(11):4208-4217.
    View in: PubMed
    Score: 0.005
  90. Characterization of Key Bio-Nano Interactions between Organosilica Nanoparticles and Candida albicans. ACS Appl Mater Interfaces. 2019 Sep 25; 11(38):34676-34687.
    View in: PubMed
    Score: 0.005
  91. Short Communication: Effect of Seminal Plasma on Functions of Monocytes and Granulocytes. AIDS Res Hum Retroviruses. 2019 06; 35(6):553-556.
    View in: PubMed
    Score: 0.005
  92. Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1. Front Immunol. 2019; 10:1025.
    View in: PubMed
    Score: 0.005
  93. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J Clin Invest. 2019 02 01; 129(2):850-862.
    View in: PubMed
    Score: 0.005
  94. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells. J Virol. 2019 02 01; 93(3).
    View in: PubMed
    Score: 0.005
  95. Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection. J Infect Dis. 2018 09 22; 218(9):1383-1393.
    View in: PubMed
    Score: 0.005
  96. Minimum information reporting in bio-nano experimental literature. Nat Nanotechnol. 2018 09; 13(9):777-785.
    View in: PubMed
    Score: 0.005
  97. Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. Hum Gene Ther. 2018 09; 29(9):1011-1028.
    View in: PubMed
    Score: 0.005
  98. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun. 2018 07 10; 9(1):2669.
    View in: PubMed
    Score: 0.005
  99. Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease. Front Immunol. 2018; 9:1076.
    View in: PubMed
    Score: 0.005
  100. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018 02 14; 10(428).
    View in: PubMed
    Score: 0.005
  101. Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV. Hum Vaccin Immunother. 2017 11 02; 13(11):2726-2737.
    View in: PubMed
    Score: 0.004
  102. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents. J Virol. 2017 05 01; 91(9).
    View in: PubMed
    Score: 0.004
  103. Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection. EBioMedicine. 2017 May; 19:119-127.
    View in: PubMed
    Score: 0.004
  104. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field. Curr HIV Res. 2017; 15(3):202-215.
    View in: PubMed
    Score: 0.004
  105. The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype. Vaccine. 2016 10 17; 34(44):5251-5261.
    View in: PubMed
    Score: 0.004
  106. Dimeric Fc?R Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG. J Immunol. 2016 08 15; 197(4):1507-16.
    View in: PubMed
    Score: 0.004
  107. Human immune cell targeting of protein nanoparticles--caveospheres. Nanoscale. 2016 Apr 21; 8(15):8255-65.
    View in: PubMed
    Score: 0.004
  108. A Potent d-Protein Antagonist of VEGF-A is Nonimmunogenic, Metabolically Stable, and Longer-Circulating in Vivo. ACS Chem Biol. 2016 Apr 15; 11(4):1058-65.
    View in: PubMed
    Score: 0.004
  109. A functional role of Rv1738 in Mycobacterium tuberculosis persistence suggested by racemic protein crystallography. Proc Natl Acad Sci U S A. 2015 Apr 07; 112(14):4310-5.
    View in: PubMed
    Score: 0.004
  110. HIV-specific antibody-dependent phagocytosis matures during HIV infection. Immunol Cell Biol. 2014 Sep; 92(8):679-87.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.